Daridorexant Trial Targets Insomnia and Alcohol Use Disorder
A clinical trial is underway to evaluate daridorexant's efficacy in reducing alcohol consumption and improving sleep in patients with insomnia and alcohol use disorder.
Asset / Drug
Drug and asset intelligence for Daridorexant with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.